In This Article:
As global markets navigate the complexities of rising inflation and shifting trade policies, U.S. stock indexes are climbing toward record highs, with growth stocks outperforming value shares. In this environment of economic uncertainty and fluctuating interest rates, dividend stocks can offer a steady income stream, making them an attractive option for investors seeking stability and potential yield in their portfolios.
Top 10 Dividend Stocks
| Name | Dividend Yield | Dividend Rating |
| Guaranty Trust Holding (NGSE:GTCO) | 5.83% | ★★★★★★ |
| Peoples Bancorp (NasdaqGS:PEBO) | 4.90% | ★★★★★★ |
| Nihon Parkerizing (TSE:4095) | 3.84% | ★★★★★★ |
| Citizens & Northern (NasdaqCM:CZNC) | 5.23% | ★★★★★★ |
| Southside Bancshares (NYSE:SBSI) | 4.60% | ★★★★★★ |
| GakkyushaLtd (TSE:9769) | 4.41% | ★★★★★★ |
| CAC Holdings (TSE:4725) | 4.12% | ★★★★★★ |
| DoshishaLtd (TSE:7483) | 3.84% | ★★★★★★ |
| Guangxi LiuYao Group (SHSE:603368) | 3.35% | ★★★★★★ |
| HUAYU Automotive Systems (SHSE:600741) | 4.28% | ★★★★★★ |
Click here to see the full list of 1977 stocks from our Top Dividend Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
G5 Entertainment
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: G5 Entertainment AB (publ) develops and publishes free-to-play games for smartphones, tablets, and personal computers in Sweden, with a market cap of SEK1.08 billion.
Operations: G5 Entertainment AB (publ) generates revenue primarily from the development and sales of casual games, amounting to SEK1.13 billion.
Dividend Yield: 5.8%
G5 Entertainment's recent earnings report shows a decline in sales but a significant increase in net income for Q4 2024. Despite only eight years of dividend history, its dividends are stable and covered by both earnings and cash flows, with payout ratios of 52.5% and 35%, respectively. The dividend yield is among the top quartile in Sweden at 5.76%. G5 is trading below estimated fair value, offering potential appeal for dividend-focused investors seeking value.
Shandong Weigao Group Medical Polymer
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Shandong Weigao Group Medical Polymer Company Limited focuses on the research, development, production, wholesale, and sale of medical devices in China with a market cap of HK$22.67 billion.
Operations: Shandong Weigao Group Medical Polymer Company Limited's revenue is derived from several segments including Orthopaedic Products (CN¥1.22 billion), Interventional Products (CN¥1.99 billion), Medical Device Products (CN¥6.74 billion), Blood Management Products (CN¥936.84 million), and Pharma Packaging Products (CN¥2.13 billion).